ERYTECH Pharma, a French biopharmaceutical company developing innovative ‘tumour starvation’ treatments for acute leukaemia, other oncology indications, announced a positive DSMB safety review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results